Composition and Method for Analysis of Target Analytes
A method of detecting analytes includes providing a mixture containing analytes to be analyzed and microparticles coated with competitive inhibitors of the analytes. First antibodies are reacted with the analytes and the competitive inhibitors under competitive binding conditions. The first antibodies bound to the competitive inhibitors are measured using flow cytometry.
1 . A method of detecting analytes, comprising the steps of:
providing a mixture containing analytes to be analyzed and microparticles coated with competitive inhibitors of the analytes;
reacting first antibodies with the analytes and the competitive inhibitors under competitive binding conditions; and
measuring the first antibodies bound to the competitive inhibitors using flow cytometry.
2 . The method of claim 1 wherein said first antibodies are labeled with a fluorescent moiety.
3 . The method of claim 2 , wherein said first antibodies are labeled by binding to second antibodies comprising a fluorescent moiety.
4 . The method of claim 1 wherein said measuring step comprises using a microcapillary flow cytometer.
5 . The method of claim 1 wherein the amount of the first antibodies is sufficient to bind about 10 to 100 percent of the competitive inhibitors on the microparticles.
6 . The method of claim 1 wherein the amount of the first antibodies is sufficient to bind about 10 to 75 percent of the competitive inhibitors on the microparticles.
7 . The method of claim 1 wherein said competitive inhibitors have a structure same or substantially same as that of said analytes.
8 . The method of claim 1 wherein said analytes are cell-associated.
9 . The method of claim 1 wherein said analytes are not cell-associated.
10 . The method of claim 1 wherein said analytes comprise hormones, enzymes, chemokines, cytokines, insulin, and signal transduction molecules.
11 . The method of claim 1 wherein said analytes are insulin.
12 . The method of claim 1 wherein said first antibodies comprise monoclonal antibodies.